Reference
Eaton EF, et al. Cost considerations in the current ARV era. AIDS : 14 Apr 2016. Available from: URL: http://doi.org/10.1097/QAD.0000000000001120
Rights and permissions
About this article
Cite this article
Efavirenz- and raltegravir-based regimens cost effective in US. PharmacoEcon Outcomes News 752, 11 (2016). https://doi.org/10.1007/s40274-016-3005-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3005-5